Stay updated on Safety of REL-1017 in Major Depressive Disorder Clinical Trial
Sign up to get notified when there's something new on the Safety of REL-1017 in Major Depressive Disorder Clinical Trial page.

Latest updates to the Safety of REL-1017 in Major Depressive Disorder Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedRevision: v3.4.2 is the new document version replacing v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check18 days agoChange DetectedPage revision updated from v3.4.0 to v3.4.1 with no substantive content changes detected; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check32 days agoChange DetectedThe page now shows a glossary and updates metadata labels related to quality control and versioning (Last Update Submitted that Met QC Criteria; No FEAR Act Data; Revision: v3.4.0), while the previous labels (Last Update Submitted that met QC Criteria; No FEAR Act data; Revision: v3.3.4) were removed.SummaryDifference0.2%

- Check39 days agoChange DetectedThe page revision note was updated from v3.3.3 to v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check68 days agoChange DetectedA consolidated 'Locations' section now lists study sites in Florida, Illinois, Massachusetts, and New York, replacing the previous separate 'Florida Locations', 'Illinois Locations', 'Massachusetts Locations', and 'New York Locations' subsections. The footer link to HHS Vulnerability Disclosure has been removed.SummaryDifference0.5%

- Check89 days agoChange DetectedThe page displays Revision: v3.3.2, replacing the previous v3.3.1.SummaryDifference0.1%

Stay in the know with updates to Safety of REL-1017 in Major Depressive Disorder Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of REL-1017 in Major Depressive Disorder Clinical Trial page.